Barely Significant
← all excerpts

Clinical-pharmacogenetic models for personalized cancer treatment: application to malignant mesothelioma.

Sci Rep · 2017 · PMC5396189 · PMID 28422153

Europe PMCDOI
1
hedged sentence
0.0010
closest p · 0.0× alpha
0.0010
boldest claim

The sentences

highly significantP < 0.001actually significant
The model performed better in first line treatment, showing highly significant association with both PFS and OS ( P < 0.001, HR = 2.82; 95% CI = 1.74–4.58 and P < 0.001, HR = 3.01; 95% CI = 1.71–5.29, respectively).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.